RP
AMED
Riverbridge Partners’s Amedisys AMED Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,235
| Closed | -$209K | – | 203 |
|
|
2023
Q3 | $209K | Sell |
2,235
-1,557,337
| -100% | -$145M | ﹤0.01% | 186 |
|
|
2023
Q2 | $143M | Buy |
1,559,572
+34,261
| +2% | +$3.13M | 1.8% | 18 |
|
|
2023
Q1 | $112M | Sell |
1,525,311
-582
| -0% | -$42.8K | 1.57% | 21 |
|
|
2022
Q4 | $127M | Sell |
1,525,893
-102,380
| -6% | -$8.55M | 1.91% | 14 |
|
|
2022
Q3 | $158M | Buy |
1,628,273
+123,286
| +8% | +$11.9M | 2.34% | 10 |
|
|
2022
Q2 | $158M | Sell |
1,504,987
-188,669
| -11% | -$19.8M | 2.53% | 6 |
|
|
2022
Q1 | $292M | Buy |
1,693,656
+104,906
| +7% | +$18.1M | 3.3% | 2 |
|
|
2021
Q4 | $257M | Buy |
1,588,750
+576,633
| +57% | +$93.3M | 2.54% | 6 |
|
|
2021
Q3 | $151M | Sell |
1,012,117
-4,506
| -0.4% | -$672K | 1.51% | 20 |
|
|
2021
Q2 | $249M | Buy |
1,016,623
+98,725
| +11% | +$24.2M | 2.53% | 5 |
|
|
2021
Q1 | $243M | Buy |
917,898
+178,664
| +24% | +$47.3M | 2.77% | 5 |
|
|
2020
Q4 | $217M | Buy |
739,234
+45,291
| +7% | +$13.3M | 2.4% | 6 |
|
|
2020
Q3 | $164M | Buy |
693,943
+21,874
| +3% | +$5.17M | 2.29% | 9 |
|
|
2020
Q2 | $133M | Buy |
672,069
+11,328
| +2% | +$2.25M | 2.09% | 14 |
|
|
2020
Q1 | $121M | Sell |
660,741
-3,198
| -0.5% | -$587K | 2.54% | 6 |
|
|
2019
Q4 | $111M | Sell |
663,939
-5,078
| -0.8% | -$848K | 1.99% | 16 |
|
|
2019
Q3 | $87.6M | Buy |
669,017
+6,261
| +0.9% | +$820K | 1.66% | 20 |
|
|
2019
Q2 | $80.5M | Buy |
+662,756
| New | +$80.5M | 1.52% | 24 |
|